Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.93B | 7.92B | 6.99B | 5.85B | 6.23B | 5.70B | Gross Profit |
2.30B | 2.30B | 1.88B | 1.47B | 1.81B | 1.79B | EBIT |
816.20M | 793.50M | 598.90M | 415.60M | 655.70M | 700.50M | EBITDA |
1.30B | 1.27B | 1.10B | 830.10M | 851.40M | 810.70M | Net Income Common Stockholders |
391.90M | 366.70M | 301.30M | 756.60M | 250.60M | 59.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
872.90M | 787.40M | 103.90M | 681.30M | 817.10M | 1.19B | Total Assets |
12.82B | 12.85B | 11.65B | 11.31B | 12.41B | 12.15B | Total Debt |
6.95B | 7.06B | 6.23B | 5.96B | 7.04B | 7.02B | Net Debt |
6.07B | 6.27B | 6.14B | 5.37B | 6.22B | 5.84B | Total Liabilities |
8.92B | 8.75B | 7.80B | 7.74B | 9.36B | 9.32B | Stockholders Equity |
3.89B | 4.09B | 3.84B | 3.25B | 2.74B | 2.85B |
Cash Flow | Free Cash Flow | ||||
580.00M | 502.20M | 447.30M | 128.90M | 395.70M | 391.00M | Operating Cash Flow |
1.07B | 931.70M | 750.30M | 384.20M | 588.20M | 625.60M | Investing Cash Flow |
-472.00M | -677.50M | -669.30M | -220.20M | -793.60M | -218.50M | Financing Cash Flow |
115.10M | 415.60M | -555.70M | -237.20M | -167.50M | -272.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $35.70B | 16.16 | 50.40% | 3.11% | 0.33% | 20.17% | |
78 Outperform | $84.45B | 19.07 | 16.69% | 2.74% | 1.18% | -5.47% | |
75 Outperform | $6.36B | 18.95 | 10.08% | ― | 7.32% | 34.44% | |
73 Outperform | $28.43B | 21.22 | 38.65% | 2.74% | -16.16% | 41.01% | |
72 Outperform | $33.70B | 13.30 | 28.02% | 3.91% | -1.48% | 11.45% | |
70 Outperform | $12.02B | 21.96 | 14.51% | 3.72% | 6.34% | -30.58% | |
63 Neutral | $20.85B | 13.27 | -10.88% | 7.48% | 1.13% | 11.50% |
Post Holdings, Inc. reported an avian influenza outbreak at a third-party egg-laying facility in Iowa, affecting about 12% of its egg supply. Despite this, the company reaffirmed its financial outlook for fiscal year 2025, projecting Adjusted EBITDA between $1,410-$1,460 million. Post uses Adjusted EBITDA, a non-GAAP measure, to evaluate performance and guide financial decisions, highlighting potential risks from the influenza incident that could impact future results.